Opko Health OPK Estimates

NASDAQ OPK
$1.50 -0.01 (-0.99%)
As of: Aug 27, 2026 · 3:59 PM EDT
Analyst Estimates

Opko Health, Inc. Quarterly Revenue Estimates

Periods 12
Next Period Q3 26
Consensus 144.68 M

Analysts expect Opko Health, Inc. to report revenue of 144.68 M for Q3 26, against a range of 138.56 M to 150.80 M. The most recent reported quarter, Q2 26, came in at 163.50 M, a 17.0% beat against the 139.74 M consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27
Reported (Actual) 173.60 M183.60 M149.90 M156.80 M151.70 M148.50 M124.20 M163.50 M----
High Estimate 189.00 M174.30 M180.39 M191.86 M168.82 M144.65 M134.76 M150.81 M150.80 M150.57 M141.49 M147.04 M
Low Estimate 155.17 M146.24 M157.38 M158.43 M138.68 M127.00 M114.65 M128.68 M138.56 M126.47 M123.03 M125.28 M
Consensus Estimate 172.09 M160.27 M168.89 M175.14 M153.75 M135.83 M124.71 M139.74 M144.68 M138.52 M132.26 M136.16 M
Analyst Estimates

Opko Health, Inc. Earnings Per Share (EPS) Estimates

Periods 26
Next Period Q3 26
Consensus -0.07

Analysts expect Opko Health, Inc. to report earnings per share of -0.07 for Q3 26, against a range of -0.07 to -0.07. The most recent reported quarter, Q2 26, came in at -0.01, a 88.9% beat against the -0.09 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) 0.030.01-0.10-0.190.03-0.04-0.07-0.01--------
High Estimate -0.10-0.09-0.07-0.10-0.06-0.06-0.07-0.08-0.07-0.06-0.07-0.07-0.05-0.08-0.07-0.06
Low Estimate -0.10-0.09-0.07-0.10-0.06-0.08-0.07-0.10-0.07-0.08-0.07-0.07-0.05-0.10-0.07-0.06
Consensus Estimate -0.10-0.09-0.07-0.10-0.06-0.07-0.07-0.09-0.07-0.07-0.07-0.07-0.05-0.09-0.07-0.06